Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

34 results about "Glucose absorption" patented technology

Glucose level management based on protein content of meals

ActiveUS12329519B2Metabolism disorderDrug and medicationsGlycemicDietary protein
Techniques for glucose level management are disclosed. In some examples, the techniques may involve obtaining an estimated protein value for a meal and determining an equivalent carbohydrate value for the meal based on the estimated protein value. In some examples, the techniques may involve obtaining an estimated fat value for a meal and determining, based on the estimated fat value, a glucose absorption rate resulting from consumption of the meal. In some examples, the equivalent carbohydrate value and / or the glucose absorption rate may be used to determine an amount of insulin to deliver to a patient to counteract a glucose level increase caused by consumption of the meal. The techniques may further involve generating an output indicative of the amount of insulin to deliver to the patient to counteract the glucose level increase caused by consumption of the meal.
Owner:MEDTRONIC MINIMED INC

Application of lactobacillus acidophilus LA85 in preparation of product with hypoglycemic effect

The invention relates to application of lactobacillus acidophilus LA85 in preparation of a product with a blood sugar reducing effect. The brand new application of the lactobacillus acidophilus LA85 strain is developed, namely the lactobacillus acidophilus LA85 strain is used for inhibiting alpha-glucosidase, reducing blood sugar and improving diabetes mellitus, and tests prove that the food intake, the water intake and the urine volume of a mouse with type II diabetes mellitus can be effectively controlled after intervention of the LA85 strain, and the weight value of the mouse is stabilized; the glucose absorption and metabolism capability of diabetic mice is effectively improved, and continuous damage of pancreatic beta cell functions is retarded; the blood lipid level disorder state of the mouse with the type II diabetes mellitus is improved; the inflammation level of a mouse body with type II diabetes mellitus is reduced, and the immunity is improved; and a very good improvement and recovery effect is achieved on abundance and diversity reduction of intestinal flora of the type II diabetes mellitus mice.
Owner:JIANGSU WECARE BIOTECHNOLOGY CO LTD

Peptide and peptide complex having antidiabetic activity and use thereof

The present invention relates to a peptide conjugate having anti-diabetic activity and uses thereof. The peptide conjugate of the present invention exhibits blood glucose level lowering efficacy by promoting glucose absorption into cells, suppressing insulin resistance signals, promoting insulin sensitivity signals, and suppressing the death of pancreatic β cells, which are insulin-producing cells. The present invention also relates to a peptide having anti-diabetic and anti-obesity activities and uses thereof. The peptide of the present invention has activities of suppressing insulin resistance signals, promoting insulin sensitivity signals, and promoting fat breakdown in adipocytes.
Owner:CAREGEN

Method and device for detecting circulating tumor cell

Provided are a method for detecting a free rare tumor cell in a human biological fluid sample and assay kit. Specifically, the method of the invention determines the existence of an active tumor cell in a biological fluid sample of a cancer patient by detecting and confirming the existence of glucose absorption capability of a karyocyte and expression of a leukocyte marker (CD45).
Owner:SHANGHAI JIAOTONG UNIV

Functional beverage based on jerusalem artichoke component and preparation method thereof

PendingCN120092884AFood thermal treatmentNatural extract food ingredientsBiotechnologyAngiotensin converting enzyme activity
The invention discloses a functional beverage based on a jerusalem artichoke component and a preparation method thereof, and belongs to the technical field of functional beverages, and the functional beverage is prepared from the following raw materials in parts by weight: 90-110 parts of jerusalem artichoke, 40-60 parts of bitter gourd, 20-40 parts of hawthorn, 40-60 parts of celery stem, 0.5-1.5 parts of ground cinnamon, 2-4 parts of sugar substitute and 300-500 parts of water. The inulin delays glucose absorption, the balsam pear glycoside promotes sugar utilization, the cinnamon polyphenol enhances insulin sensitivity to achieve sugar metabolism regulation, the jerusalem artichoke short-chain fatty acid inhibits liver cholesterol synthesis, and the hawthorn flavone promotes lipid decomposition to achieve lipid metabolism improvement. The celery potassium-sodium pump is balanced, and the inulin reduces the activity of angiotensin converting enzyme to regulate the blood pressure, so that the functional beverage can regulate the three highs.
Owner:TIANJIN VIENTIANE SHENGDA INT TRADE CO LTD

Application of PBX1 in preparation of medicine or medical apparatus for treating type 2 diabetes mellitus

The invention relates to an application of PBX1 as an active component in preparation of type 2 diabetes mellitus drugs or medical instruments, so as to relieve symptoms of diabetes mellitus, promote repair and regeneration of damaged pancreas islets and improve functions of insulin. The symptoms comprise water intake, food intake and fasting blood glucose; the method for promoting the repair and regeneration of the damaged pancreas islet comprises the steps of inhibiting the apoptosis of pancreas islet beta cells of diabetic mice, promoting the proliferation of the beta cells and recovering the tissue structure of the damaged pancreas islet; the function of improving the pancreas islet comprises the steps of stimulating secretion of insulin, improving the level of an insulin receptor, promoting absorption of an organism to glucose and reducing serum hyperglycemia and HbA1c concentration of diabetic mice, so that the effect of treating both symptoms and root causes of diabetes is achieved.
Owner:JILIN UNIVERSITY

Blood glucose level suppressants and glucose absorption inhibitors

To provide novel blood glucose level elevation inhibitors and glucose absorption inhibitors. [Solution] A blood glucose level elevation inhibitor or glucose absorption inhibitor containing sapindoside B as an active ingredient.
Owner:NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF MARINE SCIENCE AND TECHNOLOGY

Meal monitoring device and method thereof

A meal monitoring device according to an embodiment of the present invention comprises: a data reception unit that receives measurement data of a parameter related to the ear of a target object and blood sugar data of the target object; a first estimated time calculation unit that calculates a first estimated time that is estimated to be a food intake activity time of the target object on the basis of the measurement data; a second estimated time calculation unit that calculates a second estimated time that is estimated to be a glucose absorption time of the target object on the basis of the blood sugar data; and a meal time calculation unit that calculates a meal time of the target object on the basis of the first estimated time and the second estimated time.
Owner:I SENS INC

Portable apparatus for noninvasively measuring blood glucose level and operating method thereof

Disclosed in an embodiment is an operating method of portable apparatus for noninvasively measuring blood glucose levels. The method includes: (a) measuring a first signal value according to ambient environmental light when an LED for measuring signals which emits light with wavelengths to be absorbed into or scattered by glucose is switched off; (b) measuring a second signal value according to light which is scattered by or transmitted through subject tissue and enters a photodetecting unit when the LED for measuring signals is switched on; (c) calculating a glucose concentration measurement of a subject by using the first signal value and the second signal value; and (d) adjusting the quantity of the light radiated from the LED for measuring signals by feeding the difference between the glucose concentration measurement and a pre-established first reference value back to the driving current for the LED for measuring signals.
Owner:TMRW ELECTRONICS SARL

A microbinding protein targeting sodium-glucose cotransporter 2 and construction method and application thereof

The application belongs to the technical field of biological medicine, and particularly relates to a micro binding protein targeting sodium-glucose cotransporter 2 and a construction method and application thereof. The amino acid sequence of the micro binding protein is shown in SEQ ID NO. 5, and the micro binding protein is a triple helix structure. The micro binding protein targeting sodium-glucose cotransporter 2 (sglt2) provided in the application can be combined with the sglt2 protein as a tool protein, is used for regulating cell glucose absorption, and can be used for fluorescence detection of the sglt2 protein through the micro binding protein marked with a specific label. The micro binding protein in the application can be applied to sglt2 function regulation and fluorescence label detection as a novel sglt2 tool.
Owner:SOUTHWEST MEDICAL UNIV

Low-GI cooking-free blood sugar reducing rice

InactiveCN120898941AFood shapingFood ingredient functionsBiotechnologyAmylase inhibitors
The invention belongs to the technical field of hypoglycemic rice, and discloses a low-GI cooking-free hypoglycemic rice formula, which comprises the following components by mass: 200 g of rice, 15% of soybean, 150 g of kidney bean, 15% of konjaku flour, 10% of konjaku flour, 180 g of oat, 18% of Chinese yam, 12% of Chinese yam, and 10% of mung bean. Through scientific proportioning of 20% of rice, 15% of soybeans, 15% of kidney beans, 10% of konjaku flour, 18% of oat, 12% of Chinese yam and 10% of mung beans, a multi-dimensional cooperative sugar control system is constructed, the content of glucomannan in the konjaku flour is larger than or equal to 85%, a gel barrier can be formed, carbohydrate decomposition is delayed, an alpha-amylase inhibitor in the kidney beans can directly inhibit the activity of starch digestive enzymes, and the content of the glucomannan in the konjaku flour is larger than or equal to 20%. The content of beta-glucan in the oat is 5%-8%, so that the viscosity of chyme in the intestinal tract can be increased, the glucose absorption speed is slowed down, and the soybeans, the mung beans and the Chinese yams are complementary with protein through dietary fibers, so that the blood sugar rising period is further prolonged.
Owner:WUCHANG YUGUFANG GRAIN & OIL CO LTD

Noninvasive blood glucose measurement method and device, electronic equipment and storage medium

The invention provides a noninvasive blood glucose measurement method and device, electronic equipment and a storage medium, and belongs to the technical field of optical blood glucose measurement. The method comprises the steps that a target light source with the target wavelength is emitted, scattering signals of the target light source are received, and the target wavelength is the wavelength capable of being absorbed by glucose; and determining absorbance corresponding to the scattering signal, and determining blood glucose estimation information of the measured object according to the absorbance. Therefore, according to the scheme, the light source with higher correlation with the human body blood sugar is used for estimating the blood sugar, a direct and accurate basis is provided for estimating the change of the human body blood sugar level, and the accuracy of blood sugar estimation is improved. The wearable equipment is used for measuring the blood glucose, so that the blood glucose measurement convenience is improved.
Owner:BEIJING XIAOMI MOBILE SOFTWARE CO LTD

Application of premna microphylla extract in preparation of alpha-glucosidase inhibitor and hypoglycemic product

The invention relates to application of a premna microphylla extract in preparation of an alpha-glucosidase inhibitor and a hypoglycemic product, relates to the technical field of medicines and health-care products, and finds that the premna microphylla extract has a remarkable alpha-glucosidase inhibiting effect for the first time and can be applied to preparation of the alpha-glucosidase inhibitor and the hypoglycemic product. Furthermore, the premna microphylla extract and cinnamaldehyde are matched for use, blood sugar control is improved through multiple mechanisms that the premna microphylla extract delays glucose absorption and cinnamaldehyde improves insulin sensitivity, the premna microphylla extract and cinnamaldehyde have a synergistic effect, the excellent blood sugar reducing effect is shown, and the drug effect of the composition is larger than that of single use. And a new means is provided for the treatment of diabetics.
Owner:首都医科大学附属北京安贞医院南充医院(南充市中心医院川北医学院附属南充市中心医院)

Oseltamivir phosphate granules and preparation method thereof

The invention discloses oseltamivir phosphate particles and a preparation method thereof, and particularly relates to the technical field of oseltamivir particle preparation, and the preparation method comprises the following steps: raw material preparation, raw material mixing, soft material preparation, drying and grinding, whole particle sieving, and filling and sub-packaging. The oseltamivir phosphate adopting erythritol, starch slurry and water as a diluent, an adhesive and a solvent can generate relatively low heat in a body, meanwhile, the starch slurry is dissolved in water, so that the preparation cost of the oseltamivir phosphate is reduced, the starch slurry can be decomposed into glucose in the body after being taken, the glucose is absorbed into blood circulation, and the blood circulation is promoted. The oseltamivir phosphate granules have the advantages that the oseltamivir phosphate granules prepared by the aid of the method are low in toxicity and low in harm to human bodies, the oseltamivir phosphate granules are dried at the temperature of 60 DEG C for 7.5 hours when the oseltamivir phosphate granules are dried after the oseltamivir phosphate granules are prepared, accordingly, the water content of the oseltamivir phosphate granules can be reduced, the oseltamivir phosphate granules can be conveniently crushed into powder, the brown scorch rate of the oseltamivir phosphate granules can be reduced, and the yield of the
Owner:HUBEI KANGYUAN PHARMA

Auricularia auricula polysaccharide-based tablet candy for relieving hyperglycemia and preparation method thereof

The invention discloses an auricularia auricula polysaccharide-based tablet candy capable of relieving hyperglycemia and a preparation method of the auricularia auricula polysaccharide-based tablet candy, and relates to the technical field of biology, the auricularia auricula polysaccharide-based tablet candy comprises the following raw materials by weight: 20-30 parts of auricularia auricula polysaccharide; 35 to 45 parts of a filling agent; 20 to 30 parts of a disintegrating agent; 3-8 parts of a functional auxiliary material; 0.5 to 1.5 parts of a lubricant; 2-5 parts of an adhesive; wherein the auricularia auricula polysaccharide is extracted by adopting a targeted enzymolysis technology, the weight-average molecular weight is 1.0 * 10 <-2.0 > * 10 < Da >, and the bioavailability is high; the functional auxiliary material comprises an insulin secretion promoting factor and a sugar absorption inhibiting factor, and is specifically a compound of chromium yeast and a mulberry leaf extract according to a mass ratio of (1-3): 1. All the components are prepared into the tablet candy through a specific process, all the active components have a synergistic effect, and the blood sugar reducing effect can be achieved in multiple ways and multiple targets of promoting insulin secretion, inhibiting sugar absorption, improving insulin sensitivity and the like. The product is good in taste, fast in disintegration and convenient to take, can be used for preparing functional food for assisting management of type 2 diabetes, and has the blood sugar reducing effect obviously better than that of a traditional product with extracted polysaccharide or single functional factor.
Owner:WEINAN NORMAL UNIV

Glucose level management based on fat content of meals

ActiveUS12364816B2Medical simulationDrug and medicationsGlycemicGlucose absorption
Techniques for glucose level management are disclosed. In some examples, the techniques may involve obtaining an estimated protein value for a meal and determining an equivalent carbohydrate value for the meal based on the estimated protein value. In some examples, the techniques may involve obtaining an estimated fat value for a meal and determining, based on the estimated fat value, a glucose absorption rate resulting from consumption of the meal. In some examples, the equivalent carbohydrate value and / or the glucose absorption rate may be used to determine an amount of insulin to deliver to a patient to counteract a glucose level increase caused by consumption of the meal. The techniques may further involve generating an output indicative of the amount of insulin to deliver to the patient to counteract the glucose level increase caused by consumption of the meal.
Owner:MEDTRONIC MINIMED INC

Method for preparing Gynostemma pentaphyllum leaf extract and Gynostemma pentaphyllum leaf extract prepared thereby

The present disclosure relates to a method for preparing a Gynostemma pentaphyllum leaf extract, a Gynostemma pentaphyllum leaf extract prepared by the method, and a composition for improving exercise performance capacity containing the same as an active ingredient.The Gynostemma pentaphyllum leaf extract according to the present disclosure exhibits superior effect of improving exercise performance capacity and enhancing muscle strength, endurance and physical strength. In addition, the Gynostemma pentaphyllum leaf extract according to the present disclosure has the efficacy of increasing AMPK activity, facilitating beta oxidation and facilitating glucose uptake and, thus, has superior effect of reducing body weight and body fat and preventing, alleviating or treating diabetes.Because the composition of the present disclosure is derived from a natural product, it can be used usefully and safely for drugs, foods, etc. without side effects.
Owner:BIONIC TRADING CORP

Processing method for improving glucose absorption capacity of sea rice puffing powder and use of sea rice puffing powder

A processing method for improving a glucose absorption capacity of sea rice puffing powder and use of the sea rice puffing powder are disclosed. The processing method includes the following steps: mixing high-temperature resistant α-amylase with sea rice bran to obtain a mixture; and adding water to the mixture to adjust a content of water, and then performing steam explosion processing on the mixture after being adjusted the content of water. The processing method provided by the present disclosure can solve the problems of dense dietary fiber structure and poor glucose absorption capacity of sea rice, and provides theoretical basis and technical guidance for developing sea rice into special nutritious food for people with hyperglycemia or diabetes.
Owner:WUYI UNIV

Choline kinase inhibitors as a therapeutic treatment for obesity

PCT designated stageWO2025196502A1Organic active ingredientsMetabolism disorderCholine kinaseGlucose uptake
The presently-disclosed subject matter relates to using choline kinase inhibitors to treat obesity, hyperglycemia, type 2 diabetes, supporting weight loss, increasing glucose uptake, activating brown-adipose tissue thermogenesis in a subject in need thereof and / or reducing fat deposition in the liver.
Owner:LACAL SANJUAN JUAN CARLOS +2

Quinoline compound and use thereof

The present invention relates to a novel quinoline compound and a use thereof and to a novel quinoline compound exhibiting CYP4A inhibition activity and a use thereof for preventing, alleviating, treating a metabolic disease. The compound disclosed in the present invention has a remarkable effect of inhibiting CYP4A and exhibits the activities of promoting the absorption of glucose into hepatocytes, inhibiting fat accumulation in hepatocytes, suppressing endoplasmic reticulum-induced reactive oxygen species, and treating steatohepatitis, and thus can be very advantageously used for developing therapeutics for metabolic diseases such as diabetes mellitus and fatty liver.
Owner:MBD CO LTD

Composition for losing weight, reducing fat, burning fat and controlling sugar as well as preparation method and application of composition

The invention discloses a composition for losing weight, reducing fat, burning fat and controlling sugar as well as a preparation method and application thereof. The composition is composed of coconut components, coffee powder, cinnamon extract, clinacanthus nutans extract, L-carnitine, guarana extract, balsam pear extract, turmeric powder, psicose and other raw materials, all the components have a synergistic effect, carbohydrate digestion and glucose absorption are delayed by inhibiting the activity of glucosidase and amylase in the intestinal tract, and the effects of improving the immunity of the intestinal tract and improving the immunity of the intestinal tract are achieved. Meanwhile, insulin sensitivity and glucose tolerance are improved, so that accurate glucose control is achieved; secondly, by inhibiting differentiation of precursor fat cells, fat accumulation is reduced from the source, and effective lipid lowering is achieved; finally, the fat metabolism rate is accelerated by promoting the fat to be transferred into mitochondria, so that the fat is efficiently combusted, and finally the purposes of losing weight, reducing fat, combusting fat and controlling sugar are achieved. The traditional Chinese medicine composition can be prepared into various dosage forms, is suitable for people who are obese, hyperlipidemia, hyperglycemia and people who need to control body weight for slimming management, and has a wide application prospect.
Owner:JIANMA PHARM (GUANGDONG) CO LTD

Substituted C-phenyl Glycitol compound

UndeterminedPK139942AUrine glucosePharmaceutical medicine
Provided is a novel C-phenyl glycitol compound that may serve as a prophylactic or therapeutic agent for diabetes by inhibiting both SGLT1 activity and SGLT2 activity, thereby exhibiting a glucose absorption suppression action and a urine glucose excretion action. A C-phenyl glycitol compound represented by Formula (I) below or a pharmaceutically acceptable salt thereof Wherein R1 and R2 are the same or different and represent a hydrogen atom, a hydroxyl group, a C1-6 alkyl group, a C1-6 alkoxy group or a halogen atom R 3 is a hydrogen atom, a C1-6 alkyl group, a C1-6 alkoxy group or a halogen atom. Y is a C1-6 alkylene group, 0-(CH2) n- (n is an integer of 1 to 4)or a C2-6 alkenyulene group, provided that when Z is –NHC (=NH) NH2 or – NHCON (RB ) RC , n is not 1, Z is –CONHRA , -NHC(=NH) NH2 or –NHCON (RB ) RC
Owner:TAISHO PHARMACEUTICAL CO LTD

Preparation method and application of beta-acyl-C-glucoside

In the field of biomedicine, the importance and potential value of the carbon-glycoside compounds are increasingly prominent. Carbon-glucoside widely existing in medicinal plants shows remarkable physiological activity in the aspects of oxidation resistance, inflammation resistance, bacteria resistance and the like; wherein the natural product of beta-acyl-carbon-glucoside, namely Sclerpentasides A-F, is separated from a semi-parasitic plant Dendrophthoe pentras, and is used for treating the hypertension and the diabetes mellitus in the Thailand traditional medicine, so that the Sclerpentasides A-F can be used for treating the hypertension and the diabetes mellitus. Beta-acyl-carbon-glycoside is formed by acyl and glycosyl, keto carbonyl of the beta-acyl-carbon-glycoside has potential chemical conversion capacity, and a new thought is provided for modification of existing carbon-glycoside drugs. In pharmaceutical chemistry, carbon-glycosides are often used as stable mimetics of oxygen-glycosides and nitrogen-glycosides, which are designed according to the characteristics that carbon-glycosides are used as electron isosteres of oxygen glycosides in pharmaceutical chemistry and can resist hydrolase and other decomposition pathways in vivo. A high-efficiency synthetic route is designed, and beta-acyl-carbon-glucoside can be successfully constructed through two-step reaction from sugar bromoglycoside. Wherein the beta-acyl-carbon-glucoside has excellent SGLT2 inhibitory activity, can effectively inhibit glucose absorption, and can be used for controlling blood sugar and treating diabetes mellitus.
Owner:LANZHOU UNIV

Construction of Escherichia coli Nissle 1917 with high-yield L-ornithine and its probiotic function

The invention discloses the construction of Escherichia coli Nissle 1917 with high-yield L-ornithine and its probiotic function, belonging to the field of biotechnology. The invention uses the Crisper Cas9 technology to modify the metabolic pathway, constructs an L-ornithine-producing strain, overexpresses the key genes of the metabolic pathway using the screened endogenous promoter, introduces genes from Corynebacterium glutamicum to enhance the metabolic flux, and further enhances the accumulation of L-ornithine by modifying the glucose absorption pathway and L-ornithine transporter to obtain the final modified strain CEcN. Finally, the yield of L-ornithine in a 5L fermenter is 14.2 g·L-1. Male C57BL / 6J mice were randomly grouped to compare the growth effect of intragastric administration of the L-ornithine-modified strain on normal mice and its protective effect on the liver and intestine under acute alcohol conditions. The modified strain showed an obvious protective effect on the liver and intestine.
Owner:JIANGNAN UNIV

Processing method for improving glucose absorption capacity of puffed powder of sea rice and use thereof

PCT designated stage expiredWO2025152225A1Cosmetic preparationsDough treatmentAmylaseObesity
A processing method for improving the glucose absorption capacity of puffed powder of sea rice, which method comprises the following steps: adding high-temperature-resistant α-amylase into rice bran of the sea rice, mixing same to obtain a mixture, adding water into the mixture to adjust the water content, and then performing steam explosion treatment. The processing method can solve the problems of the dietary fiber structure of the sea rice being dense and the glucose absorption capacity of the sea rice being poor. The obtained puffed powder of the sea rice can be prepared into foods, medicines or cosmetics, and is suitable for people with hyperglycemia, diabetes or obesity.
Owner:WUYI UNIV

Wild mushroom sauce packet and instant konjak rice / rice noodles containing sauce packet

The invention belongs to the technical field of food engineering, and particularly relates to a wild mushroom sauce packet and instant konjac rice / rice noodles containing the sauce packet, and the wild mushroom sauce packet is prepared from the following raw materials in parts by weight: 5g of bolete, 3g of tricholoma matsutake, 4g of termitomyces albuminosus, 6g of pleurotus eryngii and 2 parts of morchella; the konjac rice bag is prepared from the following raw materials in parts by weight: 6 parts of konjac glucomannan, 2 parts of oat beta-glucan and 1 part of buckwheat flour; the konjak rice noodle bag is prepared from food-grade konjak powder and food-grade sodium carbonate; konjac glucomannan or konjac powder is adopted as the main raw material of the staple food, so that the product has multiple functions of konjac, such as strong water absorption, significant satiety enhancement, calorie intake reduction, auxiliary control of body weight, delay of glucose absorption of small intestines, reduction of postprandial blood sugar peak value and helpful adjustment of blood sugar level.
Owner:HENAN DAO SHENGYUAN COMMERCIAL OPERATION MANAGEMENT CO LTD

Application of < 18 > F-lactitol in preparation of diabetic nephropathy detection product

The invention discloses application of < 18 > F-lactitol in preparation of a diabetic nephropathy detection product, and belongs to the technical field of biomedical detection. In order to solve the problem that the action and mechanism of STRs in the kidney through SGLT2-dependent glucose reabsorption and transport are not clear yet, 18F-labeled lactitol is used, the in-vivo glucose level, kidney pathology and SGLT2 expression are detected through PET / CT, and the glucose uptake rate is labeled through in-vitro fluorescence, so that the effect and mechanism of STRs in the kidney through SGLT2-dependent glucose reabsorption and transport are determined. The method is used for evaluating the glucose reabsorption effect and mechanism of the STRs in STZ (streptozotocin)-induced diabetic mice and HK-2 cells. The result shows that the 18F-lactitol can be sensitively and specifically combined with the STRs, the biological distribution of the 18F-lactitol and the expression of the STRs in the kidney of a diabetic mouse are obviously reduced, the expression of the SGLT2 is up-regulated, and the lactitol or siRNA-STRs can obviously reduce the influence of high glucose on the expression of the STRs and the SGLT2 and glucose absorption. Therefore, the STRs can be used as a new therapeutic target for diabetes, and the < 18 > F-lactitol labeled PET / CT can become a novel probe for detecting diabetic kidney injury.
Owner:THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIV

Rolling dough wrapper containing selenium-enriched wheat component and unique preparation technology of rolling dough wrapper

The present invention discloses selenium-enriched wheat ingredient-containing rolled dough wrappers and a unique preparation technology thereof, and relates to the technical field of food processing, and the selenium-enriched wheat ingredient-containing rolled dough wrappers are prepared from the following raw materials: selenium-enriched wheat flour, soybean flour, trehalose, chitosan, almond powder, agaric powder, resistant dextrin, chia seed powder, fructo-oligosaccharide, Chinese yam powder, poria cocos powder and water. The added resistant dextrin can delay glucose absorption, the chia seed powder can increase satiety, and the resistant dextrin and the chia seed powder cooperate to help control total calorie intake; fructo-oligosaccharide can promote the growth of beneficial bacteria in intestinal tracts; chinese yam polysaccharide contained in the Chinese yam powder and beta-pachyman contained in the poria cocos powder can synergistically regulate the intestinal environment and relieve the irritation of gluten to the intestinal tract; according to the present invention, the composite strain composed of saccharomyces cerevisiae and lactobacillus plantarum is adopted to ferment, and the strain activation scheme of adding the selenium-rich malt extract to the YPD culture medium and adding the trehalose to the MRS culture medium is matched, such that the poor taste such as boring flavor, acerbity and the like easily occurring in the traditional natural fermentation or single strain fermentation is avoided;
Owner:BAOJI HEEDE DIET CULTURE MANAGEMENT CO LTD

Low-fat black steamed bun capable of reducing blood sugar and preparation method of low-fat black steamed bun

The invention belongs to the technical field of medicated steamed buns, and particularly relates to low-fat blood sugar-reducing black steamed buns and a preparation method thereof.The low-fat blood sugar-reducing black steamed buns comprise 30-50 parts of black whole wheat flour, 10-30 parts of black buckwheat flour, 10-20 parts of black highland barley flour, 5-15 parts of black bean flour, 3-7 parts of yam flour, 3-7 parts of hericium erinaceus powder, 2-4 parts of wheat bran, 1-3 parts of konjaku flour and 1 part of active dry yeast; the low-glycemic-index steamed bun has the advantages that the low-glycemic-index steamed bun is low in glycemic index, the black buckwheat flour and the konjaku flour cooperate to delay the glucose absorption speed, the glucose absorption speed is obviously lower than that of common steamed bun, the resistant starch proportion is increased, the black highland barley flour and the black bean flour provide the resistant starch, postprandial blood sugar fluctuation is reduced, part of grease is replaced with the wheat bran, lard oil / butter in a traditional formula is forbidden, and the low-glycemic-index steamed bun is suitable for large- The fat content is reduced compared with common steamed buns, and the wheat bran and the black highland barley powder provide dietary fibers and promote intestinal tract movement and satiety.
Owner:SHANXI CAOMO FOOD CO LTD

Hypoglycemic composition formula method based on large yellow tea and hypoglycemic composition

The invention belongs to the technical field of plant medicine refining and improvement, and particularly relates to a formula method of a hypoglycemic composition based on large yellow tea and the hypoglycemic composition. According to the composition method, an ethanol water solution is adopted for extracting the Huangdan tea, GRA and PLSR are adopted for correlation analysis by means of the blood glucose change dynamic of an animal model and the change dynamic of blood entering components and metabolites after animals take drugs, the blood glucose reducing composition composition method based on the Huangdan tea is constructed, four active components are obtained, and the composition is prepared through a traditional Chinese medicine method. And the composition ratio of the four active components is adjusted and screened to obtain the hypoglycemic composition with a good glucose absorption inhibition effect.
Owner:ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE